The Brutalist Report
- No new articles in the Past 6 Hours.
- No new articles in the Past 6 Hours.
- No new articles in the Past 6 Hours.
- No new articles in the Past 6 Hours.
- No new articles in the Past 6 Hours.
- No new articles in the Past 6 Hours.
- No new articles in the Past 6 Hours.
- No new articles in the Past 6 Hours.
- No new articles in the Past 6 Hours.
- No new articles in the Past 6 Hours.
- No new articles in the Past 6 Hours.
- No new articles in the Past 6 Hours.
- No new articles in the Past 6 Hours.
- No new articles in the Past 6 Hours.
- No new articles in the Past 6 Hours.
- No new articles in the Past 6 Hours.
- No new articles in the Past 6 Hours.
- No new articles in the Past 6 Hours.
- No new articles in the Past 6 Hours.
- No new articles in the Past 6 Hours.
- No new articles in the Past 6 Hours.
- No new articles in the Past 6 Hours.
- NAB Flags Higher Costs as Credit Impairments Hit Profit [170d]
- BlueScope Steel full-year profit tumbles 90% on North America impairment [170d]
- Massive Headwinds Are on the Horizon for Pharmaceutical Stocks, but Here Are 2 That Could Weather the Storm [170d]
- 5 High-Quality Dividend Stocks Yielding Well Over 5% to Buy Without Hesitation Right Now [170d]
- George Kamel: 6 Things Poor People Waste Money On [170d]
- 5 Dividend Stocks to Hold for the Next 5 Years [170d]
- Klook taps banks for US IPO, sources say [170d]
- Prediction: This Unstoppable Stock Will Be a Founding Member of the $6 Trillion Club by 2027 [170d]
- Should You Buy Broadcom Stock Before Sept. 4? Here's What the Evidence Suggests. [170d]
- Clover Health (CLOV) Achieves Profitability as Medicare Advantage Membership Surges [170d]
- Salesforce (CRM) Price Target Cut to $325 — But Stifel Stays Bullish [170d]
- GoodRx (GDRX) Lifts Guidance as Pharma Partnerships Drive Double-Digit Growth [170d]
- Why Wells Fargo Is Confident in Micron’s (MU) HBM Growth Story [170d]
- MannKind (MNKD) Secures $500M Financing to Advance Inhaled Therapies Pipeline [170d]
- OPKO Health (OPK) Advances EBV Vaccine and GLP-1 Pipeline While Streamlining Diagnostics [170d]
- LifeStance Health (LFST) Accelerates Growth with AI-Enabled Operations and Clinician Expansion [170d]
- Australia's NAB sees $85 million cost increase to fix staff underpay issue [170d]
- Recursion Pharmaceuticals (RXRX) Expands AI Drug Discovery Pipeline with New Clinical Candid [170d]
- Why Analysts Say a Chrome Divestiture Could Hurt Alphabet (GOOGL) [170d]
- Medical Properties Trust (MPW) Raises $500M to Strengthen Balance Sheet [170d]
- Why Analysts Remain Cautious on CoreWeave (CRWV) Despite Strong Growth [170d]
- AbCellera Biologics (ABCL) Advances Proprietary Pipeline with Promising Phase 1 Trial Results [170d]
- Neogen Corp (NEOG) Beats Expectations Amid Leadership Change and Restructuring Efforts [170d]
- Tilray Brands (TLRY) Boosts Revenue Mix with New Cannabis, Wellness, and Beverage Products [170d]
- Cronos Group (CRON) Posts Double-Digit Cannabis Growth and Expands International Footprint [170d]
- I Asked ChatGPT How To Turn $10 Into $1 Million: Here’s What It Said [170d]
- Prediction: Nvidia's New China Deal Will Be a Game-Changer. Here's Why [170d]
- ImmunityBio (IBRX) Reports 60% Revenue Growth as ANKTIVA Adoption Accelerates [170d]
- Vistra (VST) Projects $6 Billion EBITDA as AI Data Centers Drive Power Demand Surge [170d]
- Constellation Energy (CEG) Strikes 20-Year PPA with Meta, Boosts Nuclear Expansion Plans [170d]
- NextEra Energy (NEE) to Invest $120 Billion in Renewables and Storage Through 2029 [170d]
- Duke Energy (DUK) Reports Nearly $1 Billion Profit, Eyes $87 Billion Growth Plan [170d]
- Why Amazon’s (AMZN) Diversification Strategy Keeps It on Wall Street’s Radar [170d]
- Citi Reiterates Buy on Microsoft (MSFT), Calls It a Top Software Pick [170d]
- Piper Sandler Raises NVIDIA (NVDA) Price Target to $225 Ahead of Earnings [170d]
- Wall Street Remains Bullish on Apple (AAPL) Amid AI Upside and Resilient Earnings [170d]
- 4 Ways To Scam-Proof Yourself When Getting Into Crypto Investing [170d]
- Evercore Maintains Bullish Stance on Palo Alto (PANW) as Investors Look Past CyberArk Deal [170d]
- Amazon.com, Inc. (AMZN) Is The Largest Position In My Trust, Says Jim Cramer [170d]
- FedEx Corporation (FDX) Has A Warehouse With No People, Says Jim Cramer [170d]
- I Like Cisco Systems, Inc. (CSCO) Because Of Its AI Business, Says Jim Cramer [170d]
- Palantir Technologies Inc. (PLTR) Could Help With Government Functioning, Says Jim Cramer [170d]
- NVIDIA Corporation (NVDA): I Spend A Lot Of Time Shooting Down Rumors, Says Jim Cramer [170d]
- Advanced Micro Devices, Inc. (AMD) Is Good But The Stock Shouldn’t Have Risen Recently, Says Jim Cramer [170d]
- Constellation Brands, Inc. (STZ)’s “A Terrible Stock,” Says Jim Cramer [170d]
- Diageo plc (DEO): Use The Bounce In Share Price To Sell, Says Jim Cramer [170d]
- Brown-Forman Corporation (BF-B): Use The Bounce In Share Price To Sell, Says Jim Cramer [170d]
- Wells Fargo Says DELL Has ‘More Room to Run’ as AI Server Leader [170d]
- Interactive Brokers Group, Inc. (IBKR): “There’s Just No Fluidity,” Says Jim Cramer [170d]
- Bullish (BLSH): I Was Okay With Stock Coming Down A Little, Says Jim Cramer [170d]
- No new articles in the Past 6 Hours.
- No new articles in the Past 6 Hours.
- No new articles in the Past 6 Hours.
- No new articles in the Past 6 Hours.
- No new articles in the Past 6 Hours.
- No new articles in the Past 6 Hours.
- No new articles in the Past 6 Hours.
- No new articles in the Past 6 Hours.
- No new articles in the Past 6 Hours.
- No new articles in the Past 6 Hours.
- No new articles in the Past 6 Hours.
- No new articles in the Past 6 Hours.
- No new articles in the Past 6 Hours.
- No new articles in the Past 6 Hours.
- No new articles in the Past 6 Hours.
- No new articles in the Past 6 Hours.
- No new articles in the Past 6 Hours.
- No new articles in the Past 6 Hours.
- No new articles in the Past 6 Hours.
- No new articles in the Past 6 Hours.
- No new articles in the Past 6 Hours.
- No new articles in the Past 6 Hours.
Previous Day